Asset Details
Do you wish to reserve the book?
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Do you wish to request the book?
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
2009
Overview
Monoclonal antibodies against interleukin-5, a potent eosinophilic cytokine and growth factor, have not shown efficacy in three clinical trials
1
–
3
in patients with asthma, despite the effectiveness of this treatment in reducing the number of eosinophils in the airway and blood. This finding has raised questions about the role of eosinophils in the pathophysiology of asthma.
We reasoned that eosinophils may be in the pathobiologic chain of causation in a rare subgroup of patients with asthma who have persistent sputum eosinophilia despite treatment with oral prednisone. To test this hypothesis, we examined the prednisone-sparing effect of mepolizumab by assessing clinical . . .
Publisher
Massachusetts Medical Society
Subject
/ Adrenergic beta-Agonists - therapeutic use
/ Antibodies, Monoclonal - adverse effects
/ Antibodies, Monoclonal - therapeutic use
/ Antibodies, Monoclonal, Humanized
/ Asthma
/ Biological and medical sciences
/ Chronic obstructive pulmonary disease, asthma
/ Female
/ Forced Expiratory Volume - drug effects
/ Glucocorticoids - administration & dosage
/ Glucocorticoids - therapeutic use
/ Humans
/ Interleukin-5 - antagonists & inhibitors
/ Male
/ Prednisone - administration & dosage
